Neurology

Neurology — scientific infographic poster

Conditions

🦾ALS (Lou Gehrig's Disease) 🧠Alzheimer's Disease 🛡️Anti-LGI1 Encephalitis 🧪Anti-NMDA Receptor Encephalitis 💪Becker Muscular Dystrophy (BMD) 😐Bell's Palsy 🧬CADASIL 🚶Cerebellar Ataxia 🩸Cerebral Venous Thrombosis (CVT) 🦶Charcot-Marie-Tooth Disease (CMT) 🔻Chiari Malformation 🔌Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) 🤕Cluster Headache 🕰️Circadian Rhythm Sleep-Wake Disorders 🏈Concussion ✋Corticobasal Syndrome (CBS) ⏳Creutzfeldt-Jakob Disease (CJD) 😵‍💫Delirium 👦Duchenne Muscular Dystrophy (DMD) 🔥Encephalitis ⚡Epilepsy ☕Essential Tremor 🤷Facioscapulohumeral Muscular Dystrophy (FSHD) 🌀Friedreich's Ataxia 🎭Frontotemporal Dementia (FTD) ⬆️Guillain-Barré Syndrome 😉Hemifacial Spasm 💃Huntington's Disease 👁️Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) 😴Kleine-Levin Syndrome 📝Korsakoff Syndrome 🏋️Lambert-Eaton Myasthenic Syndrome (LEMS) 👻Lewy Body Dementia (DLB) 🌡️MCAS 🔋ME/CFS 🌩️Migraine 👓MOG Antibody Disease (MOGAD) 🦽Multiple Sclerosis 🧩Multiple System Atrophy (MSA) 🔗Myasthenia Gravis 🤝Myotonic Dystrophy (DM1 and DM2) 💤Narcolepsy 🌫️Neuromyelitis Optica (NMOSD) 💧Normal Pressure Hydrocephalus (NPH) 🤲Parkinson's Disease 🪡Peripheral Neuropathy 📈Posterior Reversible Encephalopathy Syndrome (PRES) 💓POTS 🐄Prion Disease 👀Progressive Supranuclear Palsy (PSP) 🦵Restless Leg Syndrome 👶Spinal Muscular Atrophy (SMA) 🪵Stiff-Person Syndrome 🧠Stroke 💊Subacute Combined Degeneration of the Spinal Cord 👂Susac Syndrome ⏱️TIA (Transient Ischemic Attack) 🗣️Tourette Syndrome 🦴Transverse Myelitis 😬Trigeminal Neuralgia 🧓Vascular Dementia 🍺Wernicke-Korsakoff Syndrome 💉Wernicke's Encephalopathy

Deep dives — MCAS: mediators & symptom map · testing · low-histamine diet · H1/H2 blocker stacks · cromolyn & ketotifen · triggers & flares · hereditary α-tryptasemia · natural stabilizers

Deep dives — ME/CFS: Post-Exertional Malaise (PEM) Explained · 2-Day CPET & Objective Testing · Pacing & Energy Envelope · IOM/SEID vs CCC vs ICC Criteria · Orthostatic Intolerance in ME/CFS · Post-Viral Triggers: EBV & Others · Severe & Very Severe ME · LDN, Abilify & Experimental Therapies

Deep dives — POTS: subtypes · tilt table test · salt & hydration · compression & exercise · medications · the POTS/MCAS/EDS triad · LDN · vagus nerve & retraining

Neurology focuses on disorders of the brain, spinal cord, and nervous system.

⚡ Interactive Visualization Nerve Impulse — fire an action potential Watch it race down the axon: sodium rushing in, potassium out, a live voltage trace spiking, and neurotransmitter crossing the synapse. Launch → 🔨 Interactive Visualization The Reflex Arc — fire a reflex faster than thought Tap the tendon and watch the signal fire into the spinal cord and straight back out to the muscle in ~50 ms — while the brain only finds out afterward. Launch → 🌊 Interactive Visualization Cerebrospinal Fluid — follow the brain's plumbing Make CSF at the choroid plexus and follow it around the brain and spine and back to the blood — block the aqueduct to flood the ventricles, or fall asleep and watch the glymphatic flush. Launch → 🔌 Interactive Visualization The Neuromuscular Junction — fire a nerve at a muscle Fire a nerve and watch calcium dump acetylcholine across the gap to spark the muscle — then block it with Botox, strip the receptors in myasthenia gravis, or jam the off-switch with a nerve agent. Launch →

Key Research Papers

Foundational and recent peer-reviewed publications across the major neurology subspecialties — stroke, dementia, neurodegenerative disease, multiple sclerosis, epilepsy, headache, and movement disorders. Each citation links to the full text via DOI.

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischemic Stroke. New England Journal of Medicine. 1995;333(24):1581–1587. — doi:10.1056/NEJM199512143332401
  2. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke (AHA/ASA). Stroke. 2019;50(12):e344–e418. — doi:10.1161/STR.0000000000000211
  3. Berkhemer OA, Fransen PSS, Beumer D, et al. A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke (MR CLEAN). New England Journal of Medicine. 2015;372(1):11–20. — doi:10.1056/NEJMoa1411587
  4. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (RE-LY). New England Journal of Medicine. 2009;361(12):1139–1151. — doi:10.1056/NEJMoa0905561
  5. Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation (ARISTOTLE). New England Journal of Medicine. 2011;365(11):981–992. — doi:10.1056/NEJMoa1107039
  6. Sperling RA, Aisen PS, Beckett LA, et al. Toward Defining the Preclinical Stages of Alzheimer's Disease: Recommendations from the NIA-AA Workgroups on Diagnostic Guidelines for Alzheimer's Disease. Alzheimer's & Dementia. 2011;7(3):280–292. — doi:10.1016/j.jalz.2011.03.003
  7. Sims JR, Zimmer JA, Evans CD, et al. Donanemab in Early Symptomatic Alzheimer Disease (TRAILBLAZER-ALZ 2). JAMA. 2023;330(6):512–527. — doi:10.1001/jama.2023.13239
  8. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer's Disease (CLARITY-AD). New England Journal of Medicine. 2023;388(1):9–21. — doi:10.1056/NEJMoa2212948
  9. Postuma RB, Berg D, Stern M, et al. MDS Clinical Diagnostic Criteria for Parkinson's Disease. Movement Disorders. 2015;30(12):1591–1601. — doi:10.1002/mds.26424
  10. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria. Lancet Neurology. 2018;17(2):162–173. — doi:10.1016/S1474-4422(17)30470-2
  11. Hauser SL, Bar-Or A, Comi G, et al. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis (OPERA I and II). New England Journal of Medicine. 2017;376(3):221–234. — doi:10.1056/NEJMoa1601277
  12. Bensimon G, Lacomblez L, Meininger V. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. New England Journal of Medicine. 1994;330(9):585–591. — doi:10.1056/NEJM199403033300901
  13. Brown RH Jr, Al-Chalabi A. Amyotrophic Lateral Sclerosis. New England Journal of Medicine. 2017;377(2):162–172. — doi:10.1056/NEJMra1603471
  14. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE Official Report: A Practical Clinical Definition of Epilepsy. Epilepsia. 2014;55(4):475–482. — doi:10.1111/epi.12550
  15. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd Edition. Cephalalgia. 2018;38(1):1–211. — doi:10.1177/0333102417738202
  16. Goadsby PJ, Reuter U, Hallström Y, et al. A Controlled Trial of Erenumab for Episodic Migraine. New England Journal of Medicine. 2017;377(22):2123–2132. — doi:10.1056/NEJMoa1705848

PubMed Topic Searches

Live PubMed queries that update as new papers are indexed.

  1. PubMed: neurology clinical review
  2. PubMed: neurodegenerative disease mechanisms
  3. PubMed: Alzheimer's disease
  4. PubMed: Parkinson's disease
  5. PubMed: multiple sclerosis
  6. PubMed: epilepsy management
  7. PubMed: amyotrophic lateral sclerosis
  8. PubMed: Huntington's disease
  9. PubMed: peripheral neuropathy
  10. PubMed: myasthenia gravis
  11. PubMed: ME/CFS
  12. PubMed: POTS

Connections

All Neurology Articles A–Z

Every article in this specialty, listed alphabetically.